These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6230630

  • 1. [Treatment of hypercalcemia in osteolytic metastases with oral amino-hydroxypropylidene-diphosphonate].
    Tubiana-Hulin M, de Vernejoul MC, Brière M, Miravet L, Clavel B.
    Presse Med; 1984 Feb 25; 13(8):483-6. PubMed ID: 6230630
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
    van Breukelen FJ, Bijvoet OL, van Oosterom AT.
    Lancet; 1979 Apr 14; 1(8120):803-5. PubMed ID: 86043
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD, Charhon SA, Chapuy MC, Meunier PJ.
    Rev Rhum Mal Osteoartic; 1984 Dec 15; 51(11):663-6. PubMed ID: 6523018
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Bone targeting agents: bisphosphonates].
    Debiais F.
    Bull Cancer; 2013 Nov 15; 100(11):1199-206. PubMed ID: 24158668
    [Abstract] [Full Text] [Related]

  • 8. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC, Paterson AD, Yates AJ, Beard DJ, Douglas DL, Neal FE, Russell RG, Kanis JA.
    Br J Cancer; 1985 May 15; 51(5):665-9. PubMed ID: 3158326
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
    van Breukelen FJ, Bijvoet OL, Frijlink WB, Sleeboom HP, Mulder H, van Oosterom AT.
    Calcif Tissue Int; 1982 Jul 15; 34(4):321-7. PubMed ID: 6814719
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of neoplastic hypercalcemia using single-infusion diphosphonate].
    Thiébaud D, Jaeger P, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1988 Jan 23; 118(3):77-81. PubMed ID: 3344411
    [Abstract] [Full Text] [Related]

  • 11. Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy.
    Bickerstaff DR, O'Doherty DP, McCloskey EV, Hamdy NA, Mian M, Kanis JA.
    Bone; 1991 Jan 23; 12(1):17-20. PubMed ID: 2054231
    [Abstract] [Full Text] [Related]

  • 12. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC, Meunier PJ, Alexandre CM, Vignon EP.
    J Clin Invest; 1980 May 23; 65(5):1243-7. PubMed ID: 6444955
    [Abstract] [Full Text] [Related]

  • 13. Bisphosphonates in the treatment of malignant bone disease.
    Berenson JR, Lipton A.
    Annu Rev Med; 1999 May 23; 50():237-48. PubMed ID: 10073275
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diphosphonates for osteolytic metastases.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Taube T, Lamberg-Allardt C, Borgström GH.
    Lancet; 1985 May 18; 1(8438):1155-6. PubMed ID: 2860356
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of two parenteral diphosphonates in hypercalcemia of malignancy.
    Jung A.
    Am J Med; 1982 Feb 18; 72(2):221-6. PubMed ID: 6460442
    [Abstract] [Full Text] [Related]

  • 19. A comparison of single and multiple intravenous infusions of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD) in the treatment of hypercalcemia of malignancy.
    Yates AJ, Murray RM, Jerums GJ, Martin TJ.
    Aust N Z J Med; 1987 Aug 18; 17(4):387-91. PubMed ID: 3435316
    [Abstract] [Full Text] [Related]

  • 20. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.
    Thiébaud D, Jacquet AF, Burckhardt P.
    Arch Intern Med; 1990 Oct 18; 150(10):2125-8. PubMed ID: 2222097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.